AVBP
Price:
$31.0547
Market Cap:
$1.45B
ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company’s lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-hel...[Read more]
Industry
Biotechnology
IPO Date
2024-01-26
Stock Exchange
NASDAQ
Ticker
AVBP
According to ArriVent BioPharma, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of ArriVent BioPharma, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), AVBP's Dividend Yield was at its highest in in the March 2022 quarter at 0%. The Dividend Yield was at its lowest in in the March 2022 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of ArriVent BioPharma, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | 0% |
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
The current Dividend Yield of ArriVent BioPharma, Inc. (AVBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
ArriVent BioPharma, Inc.’s Dividend Yield is less than MeiraGTx Holdings plc (0%), less than Replimune Group, Inc. (0%), less than Astria Therapeutics, Inc. (0%), less than MBX Biosciences, Inc. Common Stock (0%), less than Ginkgo Bioworks Holdings, Inc. (0%), less than Iovance Biotherapeutics, Inc. (0%), less than Valneva SE (0%), less than Erasca, Inc. (0%), less than Arvinas, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $1.15B | |
| 0% | $1.01B | |
| 0% | $718.13M | |
| 0% | $3.25B | |
| 0% | $607.52M | |
| 0% | $2.00B | |
| 0% | $499.72M | |
| 0% | $6.46B | |
| 0% | $548.11M | |
| 0% | $2.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ArriVent BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ArriVent BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is ArriVent BioPharma, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for ArriVent BioPharma, Inc. (AVBP)?
What is the highest Dividend Yield for ArriVent BioPharma, Inc. (AVBP)?
What is the 3-year average Dividend Yield for ArriVent BioPharma, Inc. (AVBP)?
What is the 5-year average Dividend Yield for ArriVent BioPharma, Inc. (AVBP)?
How does the current Dividend Yield for ArriVent BioPharma, Inc. (AVBP) compare to its historical average?